[1]浦飞飞 陈凤霞 冯晶 张志才 马陈.湖北地区骨肉瘤患者中医证型与临床病理学的相关性分析[J].中国中医骨伤科杂志,2019,27(09):42-45.
　PU Feifei CHEN Fengxia FENG Jing ZHANG Zhicai MA Chen ZHANG Haiming XIA Ping.Correlation between TCM Syndromes and Clinical Pathology of Osteosarcoma[J].Chinese Journal of Traditional Medical Traumatology & Orthopedics,2019,27(09):42-45.
点击复制

湖北地区骨肉瘤患者中医证型与临床病理学的相关性分析()
分享到：

《中国中医骨伤科杂志》[ISSN:1005-0205/CN:42-1340/R]

卷:
第27卷
期数:
2019年09期
页码:
42-45
栏目:
临床论著
出版日期:
2019-09-08

文章信息/Info

Title:
Correlation between TCM Syndromes and Clinical Pathology of Osteosarcoma
文章编号:
1005-0205(2019)09-0050-02
作者:
浦飞飞1 陈凤霞2 冯晶1 张志才3 马陈4
1武汉市中西医结合医院骨科(武汉,430022)2长江航运总医院肿瘤科3华中科技大学同济医学院附属协和医院骨科
Author(s):
PU Feifei1 CHEN Fengxia2 FENG Jing1 ZHANG Zhicai3 MA Chen4 ZHANG Haiming5 XIA Ping1△
1Department of Orthopedics,Wuhan Integrated TCM & Western Medicine Hospital,Wuhan 430022,China; 2Department of Medical Oncology,General Hospital of The Yangtze River Shipping,Wuhan 430015,China; 3Department of Orthopedics,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430022,China;
关键词:
骨肉瘤;  中医;  证型;  病理
Keywords:
osteosarcoma;  traditional Chinese medicine;  syndrome type;  pathological
分类号:
R738.1
文献标志码:
A
摘要:
目的:分析湖北地区骨肉瘤患者中医证型与临床病理的相关性,为骨肉瘤辨证论治提供理论依据。方法:统计113例骨肉瘤患者临床资料,分析其中医证型分布及其与病理类型和病理分期之间的相关性。结果:毒热炽盛证在不同的病理类型中均位于证型首位,其次为肝肾亏虚证和气滞血瘀证。Ⅱ A期主要以气滞血瘀证为主,Ⅱ B期和Ⅲ A期以毒热炽盛证为主,Ⅲ B期以肝肾亏虚证和气血不足证为主。结论:湖北地区骨肉瘤患者中医证型与骨肉瘤病理类型和病理分期中,骨肉瘤早期主要为气滞血瘀证和毒热炽盛证,晚期主要为肝肾亏虚证和气血不足证。
Abstract:
Objective:To study the correlation between TCM syndromes and clinicopathology of osteosarcoma patients,and to provide theoretical basis for the treatment of osteosarcoma based on syndrome differentiation.Methods:Clinical data of 113 patients with osteosarcoma were analyzed to analyze the distribution of TCM syndromes and their correlation with pathological types and stages.Results:In different pathological types,the incandescent syndrome of toxic heat was at the first place,followed by the deficiency of liver and kidney and qi stagnation and blood stasis.Phase Ⅱ A is mainly characterized by qi stagnation and blood stasis syndrome,

参考文献/References:

[1] GIANFERANTE D M,MIRABELLO L,SAVAGE S A.Germline and somatic genetics of osteosarcoma-connecting aetiology,biology and therapy[J].Nat Rev Endocrinol,2017,13(8):480-491. [2] 浦飞飞,邵增务.骨肉瘤基因治疗研究进展[J].国际骨科学杂志,2013,34(3):193-195. [3] VOS H I,COENEN M J,GUCHELAAR H J,et al.The role of pharmacogenetics in the treatment of osteosarcoma[J].Drug Discov Today,2016,21(11):1775-1786. [4] 黄志鹏,宋科官.骨肉瘤的诊断及治疗进展[J].国际骨科学杂志,2018,39(3):150-153. [5] 陈瑞玲,王刚阳,孙梦熊,等.骨肉瘤精准医学的实践与进展[J].中华实验外科杂志,2018,35(6):1190-1194. [6] 徐叶峰,刘云霞,陈婧,等.刘云霞主任中医师分期论治骨肉瘤思想撷箐[J].新中医,2016,48(6):212-213. [7] 王辉,孙桂芝.孙桂芝治疗骨肉瘤经验[J].世界中医药,2012,7(1):21-22. [8] 张勇,李佩文.李佩文教授中医辨证治疗骨与软组织肉瘤经验初探[J].世界最新医学信息文摘,2014,14(31):21-22. [9] 陈婧,刘云霞,姚勇伟,等.自拟护肝方治疗骨肉瘤大剂量甲氨蝶呤化疗后药物性肝损伤的临床观察[J].中国中医药科技,2015,22(2):180-181. [10] 易生辉,秦刚,黄肖华,等.自拟抑瘤汤治疗骨肉瘤保肢术后24例[J].湖北中医杂志,2017,39(9):21-23. [11] 白璧辉,谢兴文,许伟,等.谢兴文辨证论治骨肉瘤经验浅析[J].江西中医药大学学报,2018,30(5):23-25. [12] 司富春,丁帅伟.骨肉瘤中医证型与方药分析研究[J].世界中西医结合杂志,2015,10(7):903-907. [13] 张盛斌,郭利华.郭利华教授三因制宜理论治癌经验浅析[J].云南中医中药杂志,2015,36(1):40-41. [14] 关洁珊,林丽珠.“三因制宜”学说在肿瘤防治中的运用[J].世界中医药,2014,9(6):731-733. [15] 张盐,胡作为.胡作为运用清热药治疗肿瘤经验[J].湖北民族学院学报(医学版),2018,35(1):44-46. [16] 周钢,杨述华,何宇.大蒜素诱导LM-8细胞凋亡及相关基因表达的实验研究[J].中国中医骨伤科杂志,2007,15(8):6-8. [17] 周忠,王和呜.八宝丹诱导骨肉瘤细胞U～2OS凋亡及其机制的研究[J].中国中医骨伤科杂志,2007,15(5):32-34.

备注/Memo

备注/Memo:
基金项目:武汉市卫生和计划生育委员会医学科研项目(WZ18Q05) 武汉市中西医结合医院院内课题(2017Y01)2019年国家自然科学基金项目(81904231)△通信作者 E-mail:xiapingfm@126.com(收稿日期:2019-04-03)
更新日期/Last Update: 2019-09-08